(Q51985311)

19 April 2018

title

The ovine nasal mucosa: an alternative tissue site for mucosal immunization. (English)

1 reference

19 April 2018

author name string

Bradley J Sedgmen

series ordinal

1

1 reference

19 April 2018

Shari A Lofthouse

series ordinal

2

1 reference

19 April 2018

Els N T Meeusen

series ordinal

3

1 reference

19 April 2018

publication date

1 February 2006

1 reference

19 April 2018

published in

Methods

1 reference

19 April 2018

volume

38

1 reference

19 April 2018

issue

2

1 reference

19 April 2018

page(s)

112-116

1 reference

19 April 2018

The mucosal immune system: from fundamental concepts to vaccine development

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.010

Mucosal immunity of the gastrointestinal tract and oral tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.010

Evidence of M cells as portals of entry for antigens in the nasopharyngeal lymphoid tissue of humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.010

Kinetics and type of immune response following intranasal and subcutaneous immunisation of calves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.010

Characterization of ovine nasal-associated lymphoid tissue and identification of M cells in the overlying follicle-associated epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.010

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.010

Distribution of antigen specific memory T cells in lymph nodes after immunization at peripheral or mucosal sites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.010

Host/pathogen interactions at mucosal surfaces: immune consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.010

Cholera toxin adjuvant greatly promotes antigen priming of T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.010

The effect of cholera toxin and cholera toxin B subunit on the nasal mucosal membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.010

Efficacy of intra-muscular analgesics for acute pain in sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.010

The application of biodegradable collagen minipellets as vaccine delivery vehicles in mice and sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.010

Mechanisms of vaccine adjuvanticity at mucosal surfaces.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.010

Intranasal immunisation with Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.010

The B-cell system of human mucosae and exocrine glands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.010

Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.010

Comparison of the clearance of radiolabelled nose drops and nasal spray as mucosally delivered vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.010

10.1016/J.YMETH.2005.09.010

7 January 2021

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018